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At pH 4.0, the RNase T,-2’GMP complex (1) crystallizes isomorphously with the isoenzyme complex (2) 
(Heinemann, U. and Saenger, W., 1982, Nature 299,27-31). The X-ray structure of 1 was refined with 1.9 A 
data to R = 0.195. Polypeptide folding is similar in 1 and 2. However, the sugar pucker of 2’-GMP is 2’-endo 
(3’endo in 2), and guanine binding involves four hydrogen bonds in 1, which all differ from the two bonds 
in 2. Phosphate contacts Glu58, Arg77, Tyr38 in 1, but His40 in 2. These changes are not due to differences 
in sequence between the mother- and isoenzyme (Gln25-Lys) but are associated with pH changes leading 
to an inactive enzyme structure. 
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1. INTRODUCTION 
Ribonuclease Ti (RNase Tl, EC 3.1.27.3) from 
Aspergilius oryzae specifically hydrolyzes the 
3 ’ -phosphodiester bonds at guanylic acid residues 
of single-stranded RNA [l-3]. The enzyme con- 
sists of 104 amino acid residues of known sequence 
141. Spectroscopic and chemical investigations 
[l-3] indicated that His40, Glu58, Arg77 and 
His92 are located at or near the catalytic site and 
are essential for enzymatic activity, Recently the 
crystal structure of a complex between an isoen- 
zyme of RNase TI (where Gln25 is exchanged with 
Lys) and the inhibitor 2’-guanylic acid (2’GMP) 
was determined at 2.5 A resolution. The molecular 
structure obtained revealed the polypeptide chain 
folding of this enzyme and provided an under- 
standing of the base-specific recognition mode and 
of active site geometry [5,6]. 
In order to obtain a deeper understanding of the 
structure of RNase TX, the mother enzyme was 
Crystallogruphy 
cocrystallized with 2’GMP and the structure re- 
fined by stereochemical-restrained least-squares 
procedures [7] at 1.9 A resolution. Surprisingly, 
the nucleotide binding mode is found to be dif- 
ferent when compared with the earlier model. We 
associate the difference with the slightly lower pH 
of crystallization in the present work. 
2. MATERIALS AND METHODS 
The mother enzyme of RNase Ti was purified 
from Taka-diastase (Sankyo Co.) [8]. Crystalliza- 
tion of the RNase Ti-2’GMP complex was ac- 
complished as in [9] by vapor diffusion techniques 
with 2-methyl-2,Cpentanediol as precipitant. Con- 
ditions were slightly modified, i.e., concentrations 
of enzyme and 2’-GMP were 18 and 2.5 mg/ml, 
respectively, and the pH was maintained at 4.0 in 
the presence of the precipitant whereas it was 
about 5.0 in the previous study [9]. Crystals of the 
complex are orthorhombic, space group P212121 
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with a = 46.65(l), b = 50.26(l), c = 40.60(l) A; 
i.e., isomorphous to the RNase Ti isoenzyme- 
2 ’ GMP complex [9]. Individual reflection inten- 
sities, however, are not identical, suggesting some 
changes in structure and/or packing of the mole- 
cules. 
Two heavy atom derivatives were obtained by 
soaking the crystals for two days in mother liquor 
containing 2.0 mM uranyl acetate or 3.3 mM lan- 
thanum nitrate. Intensity data were collected on a 
Rigaku-Denki AFC-5 four-circle diffractometer 
using six crystals for the native data set (1.9 A 
resolution) and two crystals for each heavy atom 
derivative (2.4 A resolution). After absorption cor- 
rection [lo] and scaling [ll, 121 of the data, the 
heavy atoms were located by Patterson methods. 
The phases of native data were determined by the 
double isomorphous replacement method taking 
advantage of the anomalous dispersion effect [ 121. 
An electron density map was calculated based on 
3319 data to 2.4 A resolution using best phases 
with a figure of merit [13] of 0.784. From this 
map, a molecular model was constructed in an op- 
tical comparator [14] by means of 2 cm*A-’ Ken- 
drew wire models. The atomic coordinates meas- 
ured from the model were refined by a stereochem- 
ical-restrained least-squares technique [7]. The 
present model of the RNase Ti-2 ’ GMP complex 
consists of 781 protein and 24 inhibitor atoms and 
of 46 atoms assigned to water molecules. The con- 
ventional R factor is 0.195 for the 6396 reflections 
[FO > 301F,)] in the 5.0-I .9 A resolution range. 
3. RESULTS AND DISCUSSION 
The molecular packing and overall polypeptide 
chain folding of the mother RNase Ti-2’GMP 
complex (the low pH form, 1) is almost identical to 
that of the isoenzyme complex (the high pH form, 
2) [5,6]. The typical secondary structure elements 
are an a-helix with 4.5 turns (Ser13-Glu28) and 
a four-stranded antiparallel P-sheet @I: Pro39- 
Tyr42, ,&z: Pro55-Pro60; ,&3: Asp76-Phe80 and ,&: 
Leu86-Thr91). Like the isoenzyme, Ala87-Gly88, 
forms a P-bulge and bends the ,& strand signifi- 
cantly. 
RNase Ti has three histidyl residues, His27, 
His40 and His92, of which the latter two are con- 
sidered to be important for catalytic activity 131. 
NMR studies [ 15-171 suggested that each im- 
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Table 1 
Interactions between 2’GMP and RNase TI 
Low pH form (1) Distance (A) High pH form (2) -- 
Guanine base 
Nl-Glu460E 1 2.6 N 1 -Asn440 
N2-Asn980 2.8 06-Asn43N 
06-Asn44N 2.6 
N7-Asn43ND2 3.0 
Phosphate 
OP3-Tyr380H 2.8 
OP3-Glu580E2 2.3 
OP3-Arg77NH2 3.2 
OPl-His40NE2 
OP3-GluSSOE2 
idazole ring of these histidines interacts with an 
acidic group of the protein or the inhibitor. In the 
present model, the imidazole nitrogen atoms (NE2) 
of His27 and His40 are hydrogen bonded to the 
carboxyl groups of Glu28 and Glu58, respectively, 
but that of His92 is in contact with the peptide ox- 
ygen of Ala75. All these interactions are not seen 
in 2 because side chains are oriented differently. 
The conformations of 2 ’ GMP in 1 and 2 are 
similar when torsion angle ranges are considered: 
trans for P-02’-C2’-Cl’ , syn for glycosyl 
C8-N9-C 1’ -04 ’ and gauche( -) for 05 ‘- 
C5 ‘-C4’-04’) the latter leading to an intramole- 
cular N3.. .05’ hydrogen bonding distance of 
2.8 A. Sugar puckering modes, however, are in the 
opposite sense, i.e., C2’-endo in 1 and C3’-endo 
in 2. Consequently, the relative spatial dispositions 
of guanine base and 2’-phosphate groups are dif- 
ferent in both models. 
If 1 and 2 are compared, the most significant 
changes are found at the nucleotide binding site 
where specific guanine-protein recognition takes 
place and where phosphodiester hydrolysis is 
catalyzed, see table 1 and figs la and lb. In 2, the 
guanine base is bound by only two hydrogen bonds 
to the protein main chain peptide groups, 
Asn44CO.. .HNlGua and Asn43NH.. .06Gua. In 
contrast, in 1, four hydrogen bonds are involved, 
none of them being identical with those of 2. Two 
of these four hydrogen bonds are again to main- 
chain peptide groups, Asn98CO.. . HN2Gua and 
Asn44NH. ..06Gua, the latter showing that the 
guanine recognition site is shifted in frame by one 
peptide unit (from Asn43 to Asn44). NlH is now 
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Fig. 1. Perspective views of the nucleotide binding site [at 
the guanine base (a) and at the 2’-phosphate (b)] in the 
low pH form (1) of the RNase TI--2’GMP complex. 
Broken lines represent hydrogen bonds or ionic 
interactions. Note sandwich formed by Tyr42-Gua- 
Tyr45 in fig.lb. 
hydrogen bonded to the carboxylate of Glu46, and 
N7 accepts a hydrogen bond from the amide group 
of the side chain of Asn43. These observations are 
in line with chemical and spectroscopic data which 
suggested that N2 and N7 of guanine are not essen- 
tial for enzymatic catalysis [ l&19] but are required 
for tight binding to the enzyme [20,21]. 
The different guanine-protein hydrogen bonding 
schemes in 1 and 2 require some conformational 
changes of Glu46 and Asn43. These are located at 
the periphery of the RNase Ti molecule in 2 but are 
rotated inward to the hydrogen bond with guanine 
in 1. In both cases, the guanine base is sandwiched 
by the phenolic side chains Tyr42 and Tyr45. 
‘CI His40 
Fig.2. A drawing of the chain of hydrogen bonds 
observed at the 2’ -phosphate portion of the bound 
inhibitor molecule in the low pH form (1) of the RNase 
Tr-2’GMP complex. 
Consideration of the active site geometry also 
reveals some major differences between the two 
crystal forms, especially around the location of the 
2’-phosphate group (see fig.2). One of the 
phosphate oxygen atoms is in hydrogen bonding 
contact with Arg77NHz, Tyr380H and Glu580E2, 
The latter interaction requires a proton attached 
either to phosphate or to Glu58. In 2, the 
2 ‘-phosphate group is in hydrogen bonding con- 
tact only with the imidazole ring of His40 whereas 
the guanidinium group of Arg77 is turned away 
from the phosphate. In both crystal structures, the 
imidazole of His92 points toward the phosphate 
group but is too far to interact directly. However, 
the model building studies have shown that it 
would be favourably disposed for hydrogen bond- 
ing if a substrate with 3’GMP replaced the in- 
hibitor 15,6]. 
The differences observed in the RNase 
Tl-nucleotide interactions cannot be due to the ex- 
change of Gln25 with Lys in isoenzyme because 
amino acid 25 is located on the a-helix at the sur- 
face of the protein molecule and far away from the 
nucleotide binding site. We have to conclude 
therefore that at pH 4.0 protonation of some sites 
on the protein and/or 2’GMP give rise to different 
interactions and induce conformational changes or 
vice versa. In this sense, 2’GMP is recognized by 
RNase Ti in 2 as a non-productive ‘substrate’ with 
weak, yet specific binding whereas in 1, it is bound 
131 
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much more tightly (with more hydrogen bonds) as 
an ‘inhibitor’. 
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